Trial ID or NCT#
This is a randomized, controlled, double-blind, placebo-controlled trial of intranasal Avastin (bevacizumab) injection versus saline control for control of HHT-related epistaxis when used in conjunction with bipolar electrocautery.
Intranasal Bevacizumab for HHT-Related Epistaxis
Contact us to find out if this trial is right for you.
Amelia K Clark, MD